BioStem Technologies, Inc. (OTCMKTS:BSEM) Short Interest Update

BioStem Technologies, Inc. (OTCMKTS:BSEM - Get Free Report) was the recipient of a significant growth in short interest during the month of October. As of October 31st, there was short interest totalling 115,100 shares, a growth of 22.3% from the October 15th total of 94,100 shares. Based on an average trading volume of 124,800 shares, the days-to-cover ratio is presently 0.9 days.

BioStem Technologies Price Performance

OTCMKTS BSEM traded down 3.51 during trading hours on Friday, hitting 13.90. The company had a trading volume of 259,200 shares, compared to its average volume of 34,615. The firm's 50 day moving average is 13.52 and its 200 day moving average is 10.72. The company has a market capitalization of $231.00 million, a price-to-earnings ratio of 20.44 and a beta of -0.36. BioStem Technologies has a fifty-two week low of 2.34 and a fifty-two week high of 28.26.

BioStem Technologies (OTCMKTS:BSEM - Get Free Report) last announced its earnings results on Tuesday, November 12th. The company reported 0.32 earnings per share for the quarter, beating the consensus estimate of 0.31 by 0.01. The firm had revenue of 82.56 million during the quarter, compared to analysts' expectations of 78.22 million. On average, equities analysts anticipate that BioStem Technologies will post 1.13 EPS for the current year.

BioStem Technologies Company Profile

BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.